1
|
Fontaine M, Bartolami E, Prono M, Béal D, Blosi M, Costa AL, Ravagli C, Baldi G, Sprio S, Tampieri A, Fenoglio I, Tran L, Fadeel B, Carriere M. Nanomaterial genotoxicity evaluation using the high-throughput p53-binding protein 1 (53BP1) assay. PLoS One 2023; 18:e0288737. [PMID: 37713377 PMCID: PMC10503773 DOI: 10.1371/journal.pone.0288737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Accepted: 07/04/2023] [Indexed: 09/17/2023] Open
Abstract
Toxicity evaluation of engineered nanomaterials is challenging due to the ever increasing number of materials and because nanomaterials (NMs) frequently interfere with commonly used assays. Hence, there is a need for robust, high-throughput assays with which to assess their hazard potential. The present study aimed at evaluating the applicability of a genotoxicity assay based on the immunostaining and foci counting of the DNA repair protein 53BP1 (p53-binding protein 1), in a high-throughput format, for NM genotoxicity assessment. For benchmarking purposes, we first applied the assay to a set of eight known genotoxic agents, as well as X-ray irradiation (1 Gy). Then, a panel of NMs and nanobiomaterials (NBMs) was evaluated with respect to their impact on cell viability and genotoxicity, and to their potential to induce reactive oxygen species (ROS) production. The genotoxicity recorded using the 53BP1 assay was confirmed using the micronucleus assay, also scored via automated (high-throughput) microscopy. The 53BP1 assay successfully identified genotoxic compounds on the HCT116 human intestinal cell line. None of the tested NMs showed any genotoxicity using the 53BP1 assay, except the positive control consisting in (CoO)(NiO) NMs, while only TiO2 NMs showed positive outcome in the micronucleus assay. Only Fe3O4 NMs caused significant elevation of ROS, not correlated to DNA damage. Therefore, owing to its adequate predictivity of the genotoxicity of most of the tested benchmark substance and its ease of implementation in a high throughput format, the 53BP1 assay could be proposed as a complementary high-throughput screening genotoxicity assay, in the context of the development of New Approach Methodologies.
Collapse
Affiliation(s)
- Maelle Fontaine
- CEA, CNRS, IRIG, SyMMES-CIBEST, Univ. Grenoble Alpes, Grenoble, France
| | - Eline Bartolami
- CEA, CNRS, IRIG, SyMMES-CIBEST, Univ. Grenoble Alpes, Grenoble, France
| | - Marion Prono
- CEA, CNRS, IRIG, SyMMES-CIBEST, Univ. Grenoble Alpes, Grenoble, France
| | - David Béal
- CEA, CNRS, IRIG, SyMMES-CIBEST, Univ. Grenoble Alpes, Grenoble, France
| | - Magda Blosi
- National Research Council, Institute of Science, Technology and Sustainability for Ceramic Materials ISSMC-CNR (Former ISTEC-CNR), Faenza, Italy
| | - Anna L. Costa
- National Research Council, Institute of Science, Technology and Sustainability for Ceramic Materials ISSMC-CNR (Former ISTEC-CNR), Faenza, Italy
| | - Costanza Ravagli
- Ce.Ri.Col, Colorobbia Consulting S.R.L, Sovigliana-Vinci, Firenze, Italy
| | - Giovanni Baldi
- Ce.Ri.Col, Colorobbia Consulting S.R.L, Sovigliana-Vinci, Firenze, Italy
| | - Simone Sprio
- National Research Council, Institute of Science, Technology and Sustainability for Ceramic Materials ISSMC-CNR (Former ISTEC-CNR), Faenza, Italy
| | - Anna Tampieri
- National Research Council, Institute of Science, Technology and Sustainability for Ceramic Materials ISSMC-CNR (Former ISTEC-CNR), Faenza, Italy
| | - Ivana Fenoglio
- Department of Chemistry, University of Turin, Turin, Italy
| | - Lang Tran
- Institute of Occupational Medicine, Edinburgh, Midlothian, United Kingdom
| | - Bengt Fadeel
- Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Marie Carriere
- CEA, CNRS, IRIG, SyMMES-CIBEST, Univ. Grenoble Alpes, Grenoble, France
| |
Collapse
|
2
|
Frisch E, Clavier L, Belhamdi A, Vrana NE, Lavalle P, Frisch B, Heurtault B, Gribova V. Preclinical in vitro evaluation of implantable materials: conventional approaches, new models and future directions. Front Bioeng Biotechnol 2023; 11:1193204. [PMID: 37576997 PMCID: PMC10416115 DOI: 10.3389/fbioe.2023.1193204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Accepted: 07/12/2023] [Indexed: 08/15/2023] Open
Abstract
Nowadays, implants and prostheses are widely used to repair damaged tissues or to treat different diseases, but their use is associated with the risk of infection, inflammation and finally rejection. To address these issues, new antimicrobial and anti-inflammatory materials are being developed. Aforementioned materials require their thorough preclinical testing before clinical applications can be envisaged. Although many researchers are currently working on new in vitro tissues for drug screening and tissue replacement, in vitro models for evaluation of new biomaterials are just emerging and are extremely rare. In this context, there is an increased need for advanced in vitro models, which would best recapitulate the in vivo environment, limiting animal experimentation and adapted to the multitude of these materials. Here, we overview currently available preclinical methods and models for biological in vitro evaluation of new biomaterials. We describe several biological tests used in biocompatibility assessment, which is a primordial step in new material's development, and discuss existing challenges in this field. In the second part, the emphasis is made on the development of new 3D models and approaches for preclinical evaluation of biomaterials. The third part focuses on the main parameters to consider to achieve the optimal conditions for evaluating biocompatibility; we also overview differences in regulations across different geographical regions and regulatory systems. Finally, we discuss future directions for the development of innovative biomaterial-related assays: in silico models, dynamic testing models, complex multicellular and multiple organ systems, as well as patient-specific personalized testing approaches.
Collapse
Affiliation(s)
- Emilie Frisch
- Université de Strasbourg, CNRS UMR 7199, 3Bio Team, Laboratoire de Conception et Application de Molécules Bioactives, Faculté de Pharmacie, Strasbourg, France
| | - Lisa Clavier
- Institut National de la Santé et de la Recherche Médicale, Inserm UMR_S 1121 Biomaterials and Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, Strasbourg, France
- Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France
| | | | | | - Philippe Lavalle
- Institut National de la Santé et de la Recherche Médicale, Inserm UMR_S 1121 Biomaterials and Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, Strasbourg, France
- Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France
- SPARTHA Medical, Strasbourg, France
| | - Benoît Frisch
- Université de Strasbourg, CNRS UMR 7199, 3Bio Team, Laboratoire de Conception et Application de Molécules Bioactives, Faculté de Pharmacie, Strasbourg, France
| | - Béatrice Heurtault
- Université de Strasbourg, CNRS UMR 7199, 3Bio Team, Laboratoire de Conception et Application de Molécules Bioactives, Faculté de Pharmacie, Strasbourg, France
| | - Varvara Gribova
- Institut National de la Santé et de la Recherche Médicale, Inserm UMR_S 1121 Biomaterials and Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, Strasbourg, France
- Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France
| |
Collapse
|
3
|
Elje E, Mariussen E, McFadden E, Dusinska M, Rundén-Pran E. Different Sensitivity of Advanced Bronchial and Alveolar Mono- and Coculture Models for Hazard Assessment of Nanomaterials. NANOMATERIALS (BASEL, SWITZERLAND) 2023; 13:407. [PMID: 36770370 PMCID: PMC9921680 DOI: 10.3390/nano13030407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/25/2022] [Revised: 01/03/2023] [Accepted: 01/13/2023] [Indexed: 06/18/2023]
Abstract
For the next-generation risk assessment (NGRA) of chemicals and nanomaterials, new approach methodologies (NAMs) are needed for hazard assessment in compliance with the 3R's to reduce, replace and refine animal experiments. This study aimed to establish and characterize an advanced respiratory model consisting of human epithelial bronchial BEAS-2B cells cultivated at the air-liquid interface (ALI), both as monocultures and in cocultures with human endothelial EA.hy926 cells. The performance of the bronchial models was compared to a commonly used alveolar model consisting of A549 in monoculture and in coculture with EA.hy926 cells. The cells were exposed at the ALI to nanosilver (NM-300K) in the VITROCELL® Cloud. After 24 h, cellular viability (alamarBlue assay), inflammatory response (enzyme-linked immunosorbent assay), DNA damage (enzyme-modified comet assay), and chromosomal damage (cytokinesis-block micronucleus assay) were measured. Cytotoxicity and genotoxicity induced by NM-300K were dependent on both the cell types and model, where BEAS-2B in monocultures had the highest sensitivity in terms of cell viability and DNA strand breaks. This study indicates that the four ALI lung models have different sensitivities to NM-300K exposure and brings important knowledge for the further development of advanced 3D respiratory in vitro models for the most reliable human hazard assessment based on NAMs.
Collapse
Affiliation(s)
- Elisabeth Elje
- Health Effects Laboratory, Department for Environmental Chemistry, NILU—Norwegian Institute for Air Research, 2007 Kjeller, Norway
- Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, 0372 Oslo, Norway
| | - Espen Mariussen
- Health Effects Laboratory, Department for Environmental Chemistry, NILU—Norwegian Institute for Air Research, 2007 Kjeller, Norway
- Department of Air Quality and Noise, Norwegian Institute of Public Health, 0456 Oslo, Norway
| | - Erin McFadden
- Health Effects Laboratory, Department for Environmental Chemistry, NILU—Norwegian Institute for Air Research, 2007 Kjeller, Norway
| | - Maria Dusinska
- Health Effects Laboratory, Department for Environmental Chemistry, NILU—Norwegian Institute for Air Research, 2007 Kjeller, Norway
| | - Elise Rundén-Pran
- Health Effects Laboratory, Department for Environmental Chemistry, NILU—Norwegian Institute for Air Research, 2007 Kjeller, Norway
| |
Collapse
|
4
|
Landsiedel R, Honarvar N, Seiffert SB, Oesch B, Oesch F. Genotoxicity testing of nanomaterials. WIRES NANOMEDICINE AND NANOBIOTECHNOLOGY 2022; 14:e1833. [DOI: 10.1002/wnan.1833] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 06/02/2022] [Accepted: 06/06/2022] [Indexed: 11/24/2022]
Affiliation(s)
- Robert Landsiedel
- Experimental Toxicology and Ecology BASF SE Ludwigshafen am Rhein Germany
- Pharmacy, Pharmacology and Toxicology Free University of Berlin Berlin Germany
| | - Naveed Honarvar
- Experimental Toxicology and Ecology BASF SE Ludwigshafen am Rhein Germany
| | | | - Barbara Oesch
- Oesch‐Tox Toxicological Consulting and Expert Opinions, GmbH & Co KG Ingelheim Germany
| | - Franz Oesch
- Oesch‐Tox Toxicological Consulting and Expert Opinions, GmbH & Co KG Ingelheim Germany
- Institute of Toxicology Johannes Gutenberg University Mainz Germany
| |
Collapse
|
5
|
Vatan Ö. Evaluation of In Vitro Cytotoxic, Genotoxic, Apoptotic, and Cell Cycle Arrest Potential of Iron-Nickel Alloy Nanoparticles. TOXICS 2022; 10:492. [PMID: 36136457 PMCID: PMC9506547 DOI: 10.3390/toxics10090492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/22/2022] [Revised: 08/20/2022] [Accepted: 08/21/2022] [Indexed: 06/16/2023]
Abstract
The use of iron-nickel alloy nanoparticles (Fe-Ni ANPs) is increasing daily in various fields. People are increasingly exposed to these nanoparticles for occupational and environmental reasons. Our study determined some of the effects of Fe-Ni ANP exposure and impacts on human health at the cellular level. The cytotoxic and genotoxic potentials of Fe-Ni ANPs were investigated by XTT, clonogenic, comet, and GammaH2AX analyses using Beas-2B cells. Annexin V, multicaspase, and cell cycle arrest methods were used to understand the apoptotic mechanism of action. The intracellular ROS method was used to determine the primary mechanism that leads to cytotoxic and genotoxic activity. The Fe-Ni ANPs showed cytotoxic activity with the XTT and clonogenic methods: they had genotoxic potential, as demonstrated via genotoxicity methods. It was determined that the cytotoxic effect was realized by the caspase-dependent apoptotic pathway, and the cells were stopped at the G0/G1 stage by Fe-Ni ANPs. Increased intracellular ROS due to Fe-Ni ANPs led to cytotoxic, genotoxic, and apoptotic activity. Potential risks to human health due to Fe-Ni ANPs were then demonstrated at the cellular level.
Collapse
Affiliation(s)
- Özgür Vatan
- Department of Biology, Faculty of Arts and Science, Görükle Campus, Bursa Uludağ University, 16059 Nilüfer, Bursa, Turkey
| |
Collapse
|